G1 Therapeutics’ approach to cancer does not kill tumors. Instead, the biotech’s drug, trilaciclib, protects bone marrow from the damaging effects of chemotherapy, reducing the duration and severity ...

Just as we receive news of the demise of our good old faithful T-Mobile G1, I also have news of some testing I’ve been doing while I had the Samsung Vibrant here. The tests are all run on the T-Mobile ...

The RTP drug developer says development of the drug has gone "smoothly." In May, Mark Velleca of G1 Therapeutics promised the world would hear more from him. On Wednesday, he made that happen when G1 ...

G1 Therapeutics’ cancer drug trilaciclib has failed to beat placebo against multiple efficacy measures in phase 2. Trilaciclib performed well against its neutropenia-related primary endpoints but fell ...

LEESBURG, Va. — The National Institute for Automotive Service Excellence (ASE) is offering an online option for those taking the automobile maintenance and light repair technician (G1) certification ...